Saturday 7 November 2026
Export HUM’s income statement to Excel — free account
Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
433.74
21.95
+5.33%
Follow HUM
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| 6.65% | 6.81% | 6.20% | 6.95% | ||
| 2.33% | 2.38% | 2.13% | 2.49% | ||
ROIC |
23.68% | 17.52% | 14.31% | 16.56% | |
Return on Tangible Assets |
7.07% | 6.67% | 6.03% | 6.38% | |
Average Days of Receivables |
6.78 | 14.27 | 13.88 | 9.20 | |
Free Cash Flow per Share |
31.07 | 16.42 | 10.76 | 3.30 | |
Free Cash Flow |
3,731.00 | 1,972.00 | 1,295.00 | 398.00 | |
Capital Expenditures |
— | (567.00) | (549.00) | (523.00) | |
| Other line items | |||||
Cash ROIC |
6.60% | 3.44% | 2.37% | 0.80% | |
Accounts Receivable Turnover |
55.57 | 28.57 | 28.36 | 43.41 | |
Accounts Payable Turnover |
17.99 | 19.58 | 19.81 | 20.19 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
25.55 | 21.07 | 20.20 | 18.83 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.18) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.15% | 0.17% | 0.18% | 0.19% | |
Interest Coverage |
3.16 | 3.84 | 3.68 | 4.29 | |
Operating CF/Net income |
2.99 | 1.99 | 1.63 | 0.78 | |
Depreciation/Fixed assets |
0.37 | 0.37 | 0.37 | 0.37 | |
Capex/Depreciation |
0.00 | (0.73) | (0.68) | (0.63) | |
Revenue per Share |
1,283.87 | 1,213.32 | 1,140.18 | 1,076.46 | |
Operating CF per Share |
31.07 | 21.15 | 15.32 | 7.65 | |
Capex per Share |
0.00 | (4.72) | (4.56) | (4.34) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026